Inventor · disambiguated record
James Andrew Huntington
Also filed as: HUNTINGTON JAMES A · HUNTINGTON JAMES ANDREW
21 granted patents·6 pending applications·180 citations·filing 1994–2023
95Inventor score
Files withJANSSEN PHARMACEUTICALS INC10ALZA CORP5CENTESSA PHARMACEUTICALS UK LTD5Z FACTOR LTD4CAMBRIDGE ENTPR LTD2
Top patents by PatentIndex Score
27 records- 0195US9605082B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·11 cites·24 claims
- 0292US9518128B2Thrombin-binding antibody moleculesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Dec 13, 2016·10 cites·27 claims
- 0390US11312689B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2021·Granted Apr 26, 2022·4 cites·8 claims
- 0488US9988461B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 5, 2018·3 cites·31 claims
- 0588US9518129B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2012·Granted Dec 13, 2016·9 cites·25 claims
- 0688US6057374AComposition, device, and method for electrotransport agent deliveryALZA CORP·Filed 1997·Granted May 2, 2000·71 cites·12 claims
- 0784US9988463B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·3 cites·21 claims
- 0881US10370454B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·1 cites·5 claims
- 0974US2021371543A1Thrombin-Binding Antibody Molecules And Uses ThereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1071US11155637B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Oct 26, 2021·0 cites·13 claims
- 1169US12221422B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Feb 11, 2025·0 cites·10 claims
- 1268US9982035B2Modified serpins for the treatment of bleeding disordersCAMBRIDGE ENTPR LTD·Filed 2014·Granted May 29, 2018·1 cites·24 claims
- 1368US5883135AComposition, device, and method for enhanced electrotransport agent deliveryALZA CORP·Filed 1997·Granted Mar 16, 1999·19 cites·12 claims
- 1465US10287363B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·0 cites·7 claims
- 1564US12291507B2Compounds and their use for the treatment of ALPHA1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted May 6, 2025·0 cites·20 claims
- 1664US12286402B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Apr 29, 2025·0 cites·19 claims
- 1764US2019276558A1Thrombin-Binding Antibody Molecules And Uses ThereofJANSSEN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1862US2024197707A1Compositions and their Use for the Treatment of A1-Antitrypsin DeficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2023·Application pending·0 cites
- 1960US12365672B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Jul 22, 2025·0 cites·13 claims
- 2060US6083190ADevice for enhanced electrotransport agent deliveryALZA CORP·Filed 1998·Granted Jul 4, 2000·12 cites·7 claims
- 2160US5861439AMethod for enhanced electrotransport agent deliveryALZA CORP·Filed 1994·Granted Jan 19, 1999·11 cites·12 claims
- 2257US2024327357A14-((6-oxopyrimidin-1(6h)-yl)methyl)benzoic acid as an inducer of z a1at secretion for treating aatdZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 2353US2023089087A1Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 2452US10351619B2Modified serpins for the treatment of bleeding disordersCAMBRIDGE ENTPR LTD·Filed 2018·Granted Jul 16, 2019·0 cites·18 claims
- 2551US2023102488A1Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 2648US5811465AComposition, device, and method for electrotransport agent deliveryALZA CORP·Filed 1997·Granted Sep 22, 1998·8 cites·12 claims
- 2734US5736580AComposition, device, and method for electrotransport agent deliveryALZA CROPORATION·Filed 1994·Granted Apr 7, 1998·17 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →